Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease
Clinical trial NCT04617847 · TERMINATED
Trial details
- NCT number
- NCT04617847
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-13
- Primary completion
- 2021-05-03
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.